Shire Pharmaceuticals

Company Details

Biotech company specializing in Rare Diseases.

Shire Plc was a Jersey-registered specialty biopharmaceutical company. Originating in the United Kingdom with an operational base in the United States, its brands and products included Vyvanse, Lialda, and Adderall XR. Shire was acquired by Takeda Pharmaceutical Company on 8 January 2019.



300 Shire Way
Lexington, MA
United States

Get Full Access

 or Register to Contribute

Shire Pharmaceuticals Interview Questions

Recent interviews

View all
2018Operations AnalystLexingtonLife SciencesVery PositiveEasy

Shire Pharmaceuticals


Est Annual Revenue:

Industry: Other